[go: up one dir, main page]

KR860005778A - 나프탈렌 유도체의 제조방법 - Google Patents

나프탈렌 유도체의 제조방법

Info

Publication number
KR860005778A
KR860005778A KR1019860000074A KR860000074A KR860005778A KR 860005778 A KR860005778 A KR 860005778A KR 1019860000074 A KR1019860000074 A KR 1019860000074A KR 860000074 A KR860000074 A KR 860000074A KR 860005778 A KR860005778 A KR 860005778A
Authority
KR
South Korea
Prior art keywords
sup
formula
compounds
naphthalene derivative
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019860000074A
Other languages
English (en)
Other versions
KR890001884B1 (ko
Inventor
다메모 이와사끼
고오끼 다까시마
Original Assignee
다나베 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다나베 세이야꾸 가부시끼가이샤 filed Critical 다나베 세이야꾸 가부시끼가이샤
Publication of KR860005778A publication Critical patent/KR860005778A/ko
Application granted granted Critical
Publication of KR890001884B1 publication Critical patent/KR890001884B1/ko
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92Naphthofurans; Hydrogenated naphthofurans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33Polycyclic acids
    • C07C63/337Polycyclic acids with carboxyl groups bound to condensed ring systems
    • C07C63/34Polycyclic acids with carboxyl groups bound to condensed ring systems containing two condensed rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Fats And Perfumes (AREA)
KR1019860000074A 1985-01-10 1986-01-09 나프탈렌 유도체의 제조방법 Expired KR890001884B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP309085 1985-01-10
JP3090 1986-01-10

Publications (2)

Publication Number Publication Date
KR860005778A true KR860005778A (ko) 1986-08-13
KR890001884B1 KR890001884B1 (ko) 1989-05-29

Family

ID=11547645

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860000074A Expired KR890001884B1 (ko) 1985-01-10 1986-01-09 나프탈렌 유도체의 제조방법

Country Status (18)

Country Link
US (2) US4771072A (ko)
EP (1) EP0188248B1 (ko)
JP (3) JPS61267541A (ko)
KR (1) KR890001884B1 (ko)
CN (1) CN1006464B (ko)
AT (1) ATE54441T1 (ko)
AU (1) AU584153B2 (ko)
BG (2) BG45383A3 (ko)
DD (1) DD270529A5 (ko)
DE (1) DE3672501D1 (ko)
ES (2) ES8705837A1 (ko)
FI (1) FI87557C (ko)
HU (1) HU196737B (ko)
IL (1) IL91117A0 (ko)
MY (1) MY101268A (ko)
NO (1) NO170760C (ko)
PH (1) PH22105A (ko)
PT (1) PT81814B (ko)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
US5011948A (en) * 1985-04-12 1991-04-30 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
JPS6310746A (ja) * 1986-07-01 1988-01-18 Tanabe Seiyaku Co Ltd ナフタレン誘導体
AT388372B (de) * 1987-10-08 1989-06-12 Tanabe Seiyaku Co Neue naphthalinderivate und sie enthaltende pharmazeutika
JPH01135766A (ja) * 1987-11-20 1989-05-29 Tanabe Seiyaku Co Ltd ビフェニル誘導体
PH26342A (en) * 1988-11-29 1992-04-29 Univ Texas Microbial cellulose modified during synthesis
MY105057A (en) * 1989-01-27 1994-07-30 Tanabe Seiyaku Co A process for preparing naphthalene derivatives
US5003087A (en) * 1989-02-03 1991-03-26 Tanabe Seiyaku Co., Ltd. Process for preparing a naphthalene derivative and a synthetic intermediate thereof
EP0501579A1 (en) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Naphthalene lactones as inhibitors of leukotriene biosynthesis
EP0501578A1 (en) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
US5227399A (en) * 1991-02-28 1993-07-13 Merck Frosst Canada, Inc. Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis
US5281720A (en) * 1991-02-28 1994-01-25 Merck Frosst Canada, Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
ES2091488T3 (es) * 1991-10-17 1996-11-01 Shionogi & Co Analogo de lignano, su produccion y medicamento hipolipidemico.
US5308852A (en) * 1992-06-29 1994-05-03 Merck Frosst Canada, Inc. Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
US5426109A (en) * 1992-08-27 1995-06-20 Merck Frosst Canada, Inc. Phenylnaphthalene hydroxy acids
US5428060A (en) * 1992-08-27 1995-06-27 Merck Frosst Canada, Inc. Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
US5252599A (en) * 1992-08-27 1993-10-12 Merck Frosst Canada, Inc. Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis
US5350744A (en) * 1992-08-27 1994-09-27 Merck Frosst Canada, Inc. Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
ID18046A (id) * 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
US6306899B1 (en) 1998-08-25 2001-10-23 Yale University Inhibition and treatment of Hepatitis B virus and Flavivirus by Helioxanthin and its analogs
MXPA01012494A (es) 1999-06-01 2002-07-02 Univ Texas Southwestern Med Ct Metodo para tratar perdida capilar con el uso de compuestos sulfonil tiromimeticos.
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
AU3507700A (en) 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Method of treating hair loss using diphenylether derivatives
SE0102168D0 (sv) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
HUP0401696A2 (hu) * 2001-08-28 2004-11-29 Sankyo Co., Ltd. Angiotenzin-II receptor antagonistát tartalmazó gyógyászati készítmény
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
WO2011150286A2 (en) 2010-05-26 2011-12-01 Satiogen Pharmaceuticals,Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
BR112014010223B8 (pt) 2011-10-28 2021-02-23 Lumena Pharmaceuticals Llc uso de uma composição compreendendo inibidores de reciclagem de ácido de bílis e forma de dosagem pediátrica
EP3278796A1 (en) 2011-10-28 2018-02-07 Lumena Pharmaceuticals LLC Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
RU2015139732A (ru) 2013-03-15 2017-04-24 ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи Ингибиторы рециркуляции желчных кислот для лечения пищевода барретта и гастроэзофагеальной рефлюксной болезни
CN105228607A (zh) 2013-03-15 2016-01-06 鲁美纳医药公司 用于治疗原发性硬化性胆管炎和炎性肠病的胆汁酸再循环抑制剂
WO2015153653A1 (en) * 2014-03-31 2015-10-08 Ohio State Innovation Foundation Arylnaphthalene lactone derivatives and methods of making and using thereof
US10682367B2 (en) 2016-02-26 2020-06-16 Ohio State Innovation Foundation Antitumor arylnaphthalene ligand glycosides
AU2020223022A1 (en) 2019-02-12 2021-09-02 Mirum Pharmaceuticals, Inc. Methods for increasing growth in pediatric subjects having cholestatic liver disease

Also Published As

Publication number Publication date
EP0188248B1 (en) 1990-07-11
US4771072A (en) 1988-09-13
ATE54441T1 (de) 1990-07-15
PH22105A (en) 1988-06-01
FI87557B (fi) 1992-10-15
EP0188248A2 (en) 1986-07-23
NO170760B (no) 1992-08-24
NO170760C (no) 1992-12-02
BG45385A3 (bg) 1989-05-15
JPH0272170A (ja) 1990-03-12
EP0188248A3 (en) 1986-12-17
ES550578A0 (es) 1987-05-16
FI87557C (fi) 1993-01-25
AU5175185A (en) 1986-07-17
ES8801239A1 (es) 1987-12-16
PT81814A (en) 1986-02-01
IL91117A0 (en) 1990-03-19
JPH0549668B2 (ko) 1993-07-26
CN1006464B (zh) 1990-01-17
MY101268A (en) 1991-08-17
CN86100090A (zh) 1986-08-20
PT81814B (pt) 1988-07-29
AU584153B2 (en) 1989-05-18
BG45383A3 (bg) 1989-05-15
ES557052A0 (es) 1987-12-16
FI860089A0 (fi) 1986-01-09
DD270529A5 (de) 1989-08-02
HUT42428A (en) 1987-07-28
ES8705837A1 (es) 1987-05-16
DE3672501D1 (de) 1990-08-16
FI860089L (fi) 1986-07-11
JPS61267541A (ja) 1986-11-27
JPH0272136A (ja) 1990-03-12
HU196737B (en) 1989-01-30
KR890001884B1 (ko) 1989-05-29
US5070103A (en) 1991-12-03
NO855355L (no) 1986-07-11

Similar Documents

Publication Publication Date Title
KR860005778A (ko) 나프탈렌 유도체의 제조방법
DE3773546D1 (de) Naphthalenderivate, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen.
DE3170245D1 (en) Indane derivatives, methods of their preparation and compositions containing them
IL85988A (en) 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them
HUT70548A (en) Oxazolidone derivatives, process for producing them and pharmaceutical compositions containing them
GB1511463A (en) 1-acylamino methyl-1,2,3,4-tetrahydroisoquinolines
CA2053477A1 (en) Heterocyclic amine derivatives, their production and use
DE3683822D1 (de) Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung.
ATE68484T1 (de) Tricyclische oder tetracyclische verbindungen, deren herstellung und arzneimittel die diese enthalten.
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
HUT50788A (en) Process for producing phenoxyacetic acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
EP0316939A3 (en) Biphenyl derivatives, preparation method, pharmaceutical compositions comprising them and use
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient
ES552193A0 (es) Un procedimiento para la preparacion de nuevos peptidos.
ES8104269A1 (es) Procedimiento para la preparacion de nuevos derivados de 3-amino-1-benzoxepina
GB1242096A (en) Benzobenzofuranooxepine compounds and process for preparing the same
JPS5695188A (en) Theophyllin derivative and its production
US3028306A (en) Hypertensive 2-amino-3alpha, 4, 5, 6, 7, 7alpha-hexahydrobenzoxazole method and topical dosage preparation
EP0035853A3 (en) Thienocycloheptapyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
FR2379505A1 (fr) Nouveaux produits doues notamment de proprietes therapeutiques, leurs procedes de preparation, et medicaments a base de ces produits

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19860109

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19861105

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19860109

Comment text: Patent Application

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19890426

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19890818

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19890829

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19890829

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19920228

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 19930219

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 19930219

Start annual number: 5

End annual number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee